Profile
Dr. Shuli Kulak is a Head-Corporate Strategy & Business Development at Solid Biosciences, Inc. Dr. Kulak was previously employed as a Head-Corporate Strategy & Business Development by AavantiBio, Inc. She received her MBA from Sy Syms School of Business and a doctorate degree from Albert Einstein College of Medicine, Inc..
Shuli Kulak active positions
| Companies | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Corporate Officer/Principal | - |
Former positions of Shuli Kulak
| Companies | Position | End |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Corporate Officer/Principal | - |
Training of Shuli Kulak
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sy Syms School of Business
Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
- Stock Market
- Insiders
- Shuli Kulak
















